Skip to content

Clinical trials

Phase 2 Child Development Disorders, Pervasive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Child Development Disorders, Pervasive Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20052
20062
20071
20091
20111
20122
20161
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Withdrawn2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Drexel University College of Medicine2
Indiana University2
Massachusetts General Hospital2
Boston University1
Cambridge Health Alliance1
FDA Office of Orphan Products Development1
National Institute of Mental Health (NIMH)1
PediaMed Pharmaceuticals1
Rutgers, The State University of New Jersey1
University of Alabama at Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Child Development Disorders, Pervasive15
Autistic Disorder12
Asperger Syndrome7
Autism Spectrum Disorder6
Abdominal Pain1
Anxiety Disorders1
Bipolar Disorder1
Constipation1
Diarrhea1
Gastrointestinal Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.